Skip to main content
SpringerLink
Log in

Use of B-type Natriuretic Peptides in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Ventilatory Support

  • Chapter
Annual Update in Intensive Care and Emergency Medicine 2011

Part of the book series: Annual Update in Intensive Care and Emergency Medicine 2011 ((AUICEM,volume 1))

  • 2120 Accesses

Abstract

Chronic obstructive pulmonary disease (COPD) is expected to become the third leading cause of death by 2020 [1]. Acute exacerbation of COPD is the most frequent reason for emergency room attendance and hospital admission. It accounts for most of the burden related to the disease, including healthcare costs, social impact, and mortality [2]. Biomarkers, such as natriuretic peptides, have the advantage of being easy to obtain at affordable cost. B-type natriuretic peptide (BNP) is a 32-amino acid peptide that is released following the cleavage of pro-BNP into the biologically active BNP, and the inactive amino terminal NTproBNP [3]. BNP and NT-proBNP are closely correlated to each other and change in parallel. NT-pro BNP has a longer half-life than BNP with plasma levels 2–10 times higher than those of BNP [4]. Both are detectable in plasma and, therefore, have the potential to serve as indicators of heart failure. BNP and NT-proBNP are released into the bloodstream in response to ventricular increase in volume or pressure. BNP is the sole biologically active peptide. It increases myocardial relaxation and opposes the activation of the renin-angiotensin-aldosterone system with effects against vasoconstriction, sodium retention, and diuretic effects [3]. The diagnostic usefulness of measuring plasma levels of BNP and NT-proBNP in patients presenting to the emergency department (ED) with dyspnea is now well established [5]. High levels of natriuretic peptides accurately reflect left ventricular (LV) dysfunction and help distinguish acute dyspnea due to acute cardiac dysfunction from that of pulmonary origin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349: 1498–1504

    Article  PubMed  CAS  Google Scholar 

  2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC (2002) Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 51: 1–16

    Google Scholar 

  3. Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50: 2357–2368

    Article  PubMed  CAS  Google Scholar 

  4. Maisel A (2006) The coming of age of natriuretic peptides: the emperor does have clothes! J Am Coll Cardiol 47: 61–64

    Article  PubMed  Google Scholar 

  5. Worster A, Balion CM, Hill SA, et al (2007) Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnoea: A systematic review. Clin Biochem 41: 250–259

    Article  PubMed  Google Scholar 

  6. Le Jemtel TH, Padeletti M, Jelic S (2007) Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 49: 171–180

    Article  PubMed  Google Scholar 

  7. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW (2006) Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 8:706–711

    Article  PubMed  Google Scholar 

  8. Rutten FH, Moons KG, Cramer MJ, et al (2005) Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331: 1379

    Article  PubMed  Google Scholar 

  9. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM (2002) Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J 143: 412–417

    Article  PubMed  Google Scholar 

  10. Masoudi FA, Havranek EP, Krumholz HM (2002) The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev 7: 9–16

    Article  PubMed  Google Scholar 

  11. Braunstein JB, Anderson GF, Gerstenblith G, et al (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42: 1226–1233

    Article  PubMed  Google Scholar 

  12. Curkendall SM, DeLuise C, Jones JK, et al (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 16: 63–70

    Article  PubMed  Google Scholar 

  13. Abroug F, Ouanes-Besbes L, Nciri N, et al (2006) Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 174: 990–996

    Article  PubMed  Google Scholar 

  14. Lemaire F, Teboul JL, Cinotti L, et al (1988) Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology 69: 171–179

    Article  PubMed  CAS  Google Scholar 

  15. Rutten FH, Cramer MJ, Grobbee DE, et al (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26: 1887–1894

    Article  PubMed  Google Scholar 

  16. Richard C, Teboul JL (2005) Weaning failure from cardiovascular origin. Intensive Care Med 31: 1605–1607

    Article  PubMed  Google Scholar 

  17. Teboul JL, Richard C (2006) How to diagnose weaning-induced pulmonary edema? Intensive Care Med 32: 938

    Article  Google Scholar 

  18. Monnet X, Teboul JL, Richard C (2007) Cardiopulmonary interactions in patients with heart failure. Curr Opin Crit Care 13: 6–11

    Article  PubMed  Google Scholar 

  19. Jubran A, Mathru M, Dries D, Tobin MJ (1998) Continuous recordings of mixed venous oxygen saturation during weaning from mechanical ventilation and the ramifications thereof. Am J Respir Crit Care Med 158: 1763–1769

    PubMed  CAS  Google Scholar 

  20. MacIntyre NR, Cook DJ, Ely EW Jr, et al (2001) Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest 120: 375S–395S

    Article  PubMed  CAS  Google Scholar 

  21. Alia I, Esteban A (2000) Weaning from mechanical ventilation. Crit Care 4: 72–80

    Article  PubMed  CAS  Google Scholar 

  22. Lainchbury JG, Campbell E, Frampton CM, et al (2003) Brain natriuretic peptide and nterminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42: 728–735

    Article  PubMed  CAS  Google Scholar 

  23. Maisel AS, Krishnaswamy P, Nowak RM, et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161–167

    Article  PubMed  CAS  Google Scholar 

  24. Dao Q, Krishnaswamy P, Kazanegra R, et al (2001) Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37:379–385

    Article  PubMed  CAS  Google Scholar 

  25. Ray P, Arthaud M, Lefort Y, Birolleau S, Beigelman C, Riou B (2004) Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnoea. Intensive Care Med 30:2230–2236

    Article  PubMed  Google Scholar 

  26. Villacorta H, Duarte A, Duarte NM, et al (2002) The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnoea. Arq Bras Cardiol 79: 569–572, 564-568

    Article  PubMed  Google Scholar 

  27. Barcarse E, Kazanegra R, Chen A, Chiu A, Clopton P, Maisel A (2004) Combination of Btype natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. Congest Heart Fail 10: 171–176

    Article  PubMed  CAS  Google Scholar 

  28. Bayes-Genis A, Santalo-Bel M, Zapico-Muniz E, et al (2004) N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 6: 301–308

    Article  PubMed  CAS  Google Scholar 

  29. Jose JV, Gupta SN, Selvakumar D (2003) Utility of N-terminal pro-brain natriuretic peptide for the diagnosis of heart failure. Indian Heart J 55: 35–39

    PubMed  Google Scholar 

  30. Logeart D, Saudubray C, Beyne P, et al (2002) Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnoea. J Am Coll Cardiol 40: 1794–1800

    Article  PubMed  Google Scholar 

  31. Klinger JR, Arnal F, Warburton RR, Ou LC, Hill NS (1994) Downregulation of pulmonary atrial natriuretic peptide receptors in rats exposed to chronic hypoxia. J Appl Physiol77: 1309–1316

    PubMed  CAS  Google Scholar 

  32. Nagaya N, Nishikimi T, Okano Y, et al (1998) Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31: 202–208

    Article  PubMed  CAS  Google Scholar 

  33. Bozkanat E, Tozkoparan E, Baysan O, Deniz O, Ciftci F, Yokusoglu M (2005) The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease. J Int Med Res 33: 537–544

    PubMed  CAS  Google Scholar 

  34. Lang CC, Coutie WJ, Struthers AD, Dhillon DP, Winter JH, Lipworth BJ (1992) Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond) 83: 529–533

    CAS  Google Scholar 

  35. Bando M, Ishii Y, Sugiyama Y, Kitamura S (1999) Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 93: 507–514

    Article  PubMed  CAS  Google Scholar 

  36. Ishii J, Nomura M, Ito M, et al (2000) Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 301: 19–30

    Article  PubMed  CAS  Google Scholar 

  37. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnoea. J Am Coll Cardiol 39: 202–209

    Article  PubMed  CAS  Google Scholar 

  38. McCullough PA, Hollander JE, Nowak RM, et al (2003) Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10: 198–204

    Article  PubMed  Google Scholar 

  39. Rutten FH, Cramer MJ, Zuithoff NP, et al (2007) Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 9: 651–659

    Article  PubMed  CAS  Google Scholar 

  40. Ouanes-Besbes L, Ouanes I, Dachraoui F, Dimassi S, Mebazaa A, Abroug F (2011) Weaning difficult-to-wean chronic obstructive pulmonary disease patients: A pilot study comparing initial hemodynamic effects of levosimendan and dobutamine. J Crit Care (in press)

    Google Scholar 

  41. Grasso S, Leone A, De Michele M, et al (2007) Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease. Crit Care Med 35: 96–105

    Article  PubMed  CAS  Google Scholar 

  42. Mekontso-Dessap A, de Prost N, Girou E, et al (2006) B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 32: 1529–1536

    Article  PubMed  CAS  Google Scholar 

  43. Chien JY, Lin MS, Huang YC, Chien YF, Yu CJ, Yang PC (2008) Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial. Crit Care Med 36: 1421–1426

    Article  PubMed  CAS  Google Scholar 

  44. Meyer B, Huelsmann M, Wexberg P, et al (2007) N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 35: 2268–2273

    Article  PubMed  CAS  Google Scholar 

  45. Kotanidou A, Karsaliakos P, Tzanela M, et al (2009) Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock 31: 342–347

    Article  PubMed  CAS  Google Scholar 

  46. Sturgess DJ, Marwick TH, Joyce C, et al (2010) Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care 14:R44

    Article  PubMed  Google Scholar 

  47. Song JW, Song JK, Kim DS (2009) Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med 103: 180–186

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Intensive Care Unit, CHU Fatouma Bourguiba, Av. du 1er Juin, 5000, Monastir, Tunisia

    F. Dachraoui, L. Ouanes-Besbes & F. Abroug

Authors
  1. F. Dachraoui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Ouanes-Besbes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Abroug
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Dachraoui, F., Ouanes-Besbes, L., Abroug, F. (2011). Use of B-type Natriuretic Peptides in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Ventilatory Support. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2011. Annual Update in Intensive Care and Emergency Medicine 2011, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18081-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18081-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-18080-4

  • Online ISBN: 978-3-642-18081-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation